Prot #SGNTV-003: A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date12/4/20 → 12/4/23

Funding

  • Gynecologic Oncology Group (Prot #SGNTV-003)
  • Seattle Genetics, Inc. (Prot #SGNTV-003)